Mitogen immunotherapy for hiv infections exemplified by phytohemagglutinin and pokeweed mitogen

Cancer Biotherapy and Radiopharmaceuticals

Volumn 15, Issue 6, 2000, Pages 629-644

  Wimer, B M ^a   Mann, P L ^b  

^a JBMW Immunotherapeutics   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Drug holidays; HIV infection; Nonnucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors; PHA; Plant mitogens; Protease inhibitors; PWM

Indexed keywords

ANTIRETROVIRUS AGENT; MITOGENIC AGENT; NUCLEOSIDE DERIVATIVE; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG RESEARCH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

EID: 0034520871     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2000.15.629     Document Type: Article

References (48)

1. The role of immunotherapy in the treatment of HIV
2. HIV patients who quit drug combo and thrive offer researchers clues
3. Causal pathways for CCR5 genotype and HIV progression
4. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, O'Brien SJ. Genetic restriction of HIV- 1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
5. CD8 cells, HIV, and the aging immune system
6. The rationale of using phytohemagglutinin PHA) as both adoptive cell activator and host immunopotentiator for immunotherapy of hematologic malignancies
7. Therapeutic immunostimulating effects of plant mitogens exemplified by the L4 isotectin of PHA
8. Theoretical benefits of mitogen applications for HIV-1 infections
9. Putative effects of mitogenic lectin therapy corroborated by alloactivation data
10. Enhanced basophil histamine release to concanavalin A in allergic rhinitis
11. Therapeutic activities of PHA-L4 the mitogenic isolectin of phytohemagglutinin
12. Potential therapeutic applications of PHA-L4 the mitogenic isolectin of phytohemagglutinin
13. The ideal biological response modifier
14. Characteristics of PHA-L4 the mitogenic isolectin of phytohemagglutinin as an ideal biological response modifier
15. Chemokines and HIV second receptors: A short history of a recent breakthrough
16. Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV- 1-1) pathogenesis
17. Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV-1) infectivity and virus-induced cell fusion
18. A diet containing the lectin phytohaemagglutlnin (PHA) slows down the proliferation of Krebs II cell tumours in mice
19. PHA for aplastic anemias: The alpha but not the omega of mitogen therapies
20. The functions and mechanisms of action of cytolytic lymphocytes
21. Affinity of phytohemag-glutinin (PHA) isolectins for serum proteins and regulation of the lectin-induced lymphocyte transformation
22. Phytohemagglutinin skin tests in cancer patients
23. The effects of intravenous phytohaemagglutinin in a patient with disseminated malignant melanoma. A clinical and immunological study
24. Amelioration of immunologic deficits and clinical manifestations of the acquired immunodeficiency syndrome (AIDS) by allogeneic lymphocyte transfusions
25. Multifactorial nature of human deficiency virus disease: Implications for therapy
26. Autoradiographic studies of lymphocytes stimulated in vitro with tritium labeled kidney bean leucoagglutinin
27. Kinetics of the reaction of kidney-bean leucoagglutinin with human lymphocytes
28. Mechanism of phytohemag-glutinin (PHA) action. V. PHA compared with concanavalin A (Con A)
29. Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with phytohemagglutinin
30. Isolation, characterization, and biological activities of five mitogens from pokeweed
31. Purification and biological activities of Pokeweed (Phytolacca americana) mitogens
32. Biomodulation: An integrated approach to access and manipulate biological information
33. Biomodulators in cancer treatment
34. Apparent pokeweed mitogen cure of metastatic gum melanoma in an older dog
35. Morphology and lytic mechanisms of interleukin 3-dependent natural cytotoxic cells: Tumor necrosis factor as a possible mediator
36. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin
37. Stem cell factor and hematopoiesis
38. Mitogenic activity in Phytolacca americana (pokeweed)
39. Mitogenic activity in Phytolacca americana (pokeweed)
40. Peripheral blood plasmacytosis following systemic exposure to Phytolacca americana (pokeweed)
41. Care for a dying continent
42. The AIDS epidemic. Considerations for the 21st century